High time for common ground in the assessment of steatosis
Benjamin Philosophe, Russell Noel Wesson – 20 May 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, Georg Semmler, Mathias Schneeweiss‐Gleixner, Mathias Jachs, Benedikt Simbrunner, David Josef Maria Bauer, Ernst Eigenbauer, Robert Strassl, Monika Breuer, Oliver Kimberger, Daniel Laxar, Katharina Lampichler, Emina Halilbasic, Albert Friedrich Stättermayer, Ahmed Ba‐Ssalamah, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, Michael Trauner – 20 May 2022
Use of preprocurement biopsy in donation after circulatory death liver transplantation
Alexandra C. Bolognese, David P. Foley, Carrie J. Sparks, Adam K. Schneider, Anthony M. D'Alessandro, Nikole A. Neidlinger – 20 May 2022 – We perform routine preprocurement image‐guided percutaneous liver biopsies on potential donation after circulatory death (DCD) liver donors. The purpose of this study was to examine the impact of preprocurement liver biopsy on the use of livers from DCD donors.
Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports
Einar S. Björnsson, Inmaculada Medina‐Caliz, Raul J. Andrade, M. Isabel Lucena – 20 May 2022 – Nitrofurantoin, minocycline, methyldopa and infliximab, have been found to induce autoimmune‐like hepatitis (DI‐AILH). Evidence for other drugs and herbal and dietary supplements (HDS) is unclear. The aims of the study were to establish criteria to define and review the published evidence of suspected DI‐AILH.
Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Posttransplant complications in the setting of acute‐on‐chronic liver failure and considerations regarding immunosuppression
M. Valerie Lin, Fredric D. Gordon – 19 May 2022
Con: Patients With Acute‐on‐Chronic Liver Failure Should Not Receive Priority on the Waiting List
Nadim Mahmud, K. Rajender Reddy – 19 May 2022
Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Palliative Care in the Patient With Acute‐on‐Chronic Liver Failure
Kinjal Patel, Puneeta Tandon, Ruben Hernaez – 19 May 2022
Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats
Lakmie S. Gunarathne, Indu G. Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W. Angus, Chandana B. Herath – 19 May 2022 – Splanchnic vasodilatation contributes to the development and aggravation of portal hypertension (PHT). We previously demonstrated that in cirrhosis, angiotensin‐ mediates splanchnic vasodilatation through the Mas receptor (MasR).